Screening for lung cancer: A systematic review and meta-analysis

Preventive Medicine

Volumn 89, Issue , 2016, Pages 301-314

  Usman Ali, Muhammad ^a   Miller, John ^a   Peirson, Leslea ^a   Fitzpatrick Lewis, Donna ^a   Kenny, Meghan ^a   Sherifali, Diana ^a   Raina, Parminder ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Lung cancer; Primary health care; Screening; Systematic review

Indexed keywords

ANXIETY; CANCER MORTALITY; CANCER SCREENING; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ERROR; FALSE POSITIVE RESULT; HIGH RISK POPULATION; HUMAN; INCIDENTAL FINDING; INFECTION; INVASIVE PROCEDURE; LUNG CANCER; OVERDIAGNOSIS; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SMOKING CESSATION; SPUTUM CYTODIAGNOSIS; SYSTEMATIC REVIEW; THORAX RADIOGRAPHY; CANADA; DIAGNOSTIC IMAGING; EARLY CANCER DIAGNOSIS; LUNG NEOPLASMS; MASS SCREENING; META ANALYSIS; MORTALITY; PROCEDURES; RISK FACTOR; STANDARDS; TRENDS; X-RAY COMPUTED TOMOGRAPHY;

CANADA; EARLY DETECTION OF CANCER; HUMANS; LUNG NEOPLASMS; MASS SCREENING; MORTALITY; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84989810476     PISSN: 00917435     EISSN: 10960260     Source Type: Journal    
DOI: 10.1016/j.ypmed.2016.04.015     Document Type: Review

References (90)

1. Alberts, W.M., American College of Chest Physicians, Introduction: diagnosis and management of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 132:Suppl. 3 (2007), S20–S22 (Available from: http://www.ncbi.nlm.nih.gov/pubmed/17873157).
2. American Lung Association, Providing guidance on lung cancer screening to patients and physicians. 2013 ([Internet], Washington, DC, Available from: http://www.lung.org/lung-disease/lung-cancer/lung-cancer-screening-guidelines/lung-cancer-screening.pdf).
3. Armstrong, C., ACS Releases Guideline on Screening for Lung Cancer with Low-Dose Computed Tomography., 89(1), 2014, 56–57 (Available from).
4. Ashraf, H., Saghir, Z., Dirksen, A., Pedersen, J.H., Thomsen, L.H., Døssing, M., et al. Smoking habits in the randomised Danish Lung Cancer Screening Trial with low-dose CT: final results after a 5-year screening programme. Thorax 69:6 (2014), 574–579 (Available from: http://thorax.bmj.com/content/early/2014/01/17/thoraxjnl-2013-203849.abstract).
5. Baker, R.R., Tockman, M.S., Marsh, B.R., Stitik, F.P., Ball, W.C. Jr., Eggleston, J.C., et al. Screening for bronchogenic carcinoma: the surgical experience. J. Thorac. Cardiovasc. Surg. 78:6 (1979), 876–882 (Available from: http://www.ncbi.nlm.nih.gov/pubmed/502570).
6. Becker, N., Motsch, E., Gross, M.L., Eigentopf, A., Heussel, C.P., Dienemann, H., et al. Randomized study on early detection of lung cancer with MSCT in Germany: study design and results of the first screening round. J. Cancer Res. Clin. Oncol. 138:9 (2012), 1475–1486 (Available from: http://www.ncbi.nlm.nih.gov/pubmed/?term=22526165).
7. Black, W.C., Gareen, I.F., Soneji, S.S., Sicks, J.D., Keeler, E.B., Aberle, D.R., et al. Cost-effectiveness of CT screening in the National Lung Screening Trial. N. Engl. J. Med. 371:19 (2014), 1793–1802 (Available from: http://www.nejm.org/doi/full/10.1056/NEJMoa1312547).
8. Blanchon, T., Brechot, J.M., Grenier, P.A., Ferretti, G.R., Lemarie, E., Milleron, B., et al. Baseline results of the Depiscan study: a French randomized pilot trial of lung cancer screening comparing low dose CT scan (LDCT) and chest X-ray (CXR). Lung Cancer 58:1 (2007), 50–58 (Available from: http://www.ncbi.nlm.nih.gov/pubmed/17624475).
9. Byrne, M.M., Weissfeld, J., Roberts, M.S., Anxiety, fear of cancer, and perceived risk of cancer following lung cancer screening. Med. Decis. Mak. 28:6 (2008), 917–925 (Available from: http://www.ncbi.nlm.nih.gov/pubmed/18725404).
10. Callol, L., Roig, F., Cuevas, A., de Granda, J.I., Villegas, F., Jareño, J., et al. Low-dose CT: a useful and accessible tool for the early diagnosis of lung cancer in selected populations. Lung Cancer 56:2 (2007), 217–221 (Available from: http://www.sciencedirect.com/science/article/pii/S0169500207000025).
11. Canadian Cancer Society's Advisory Committee on Cancer Statistics, Canadian Cancer Statistics 2015. Special Topic: Predictions of the Future Burden of Cancer in Canada, 2015 (Toronto, ON Available from: http://www.cancer.ca/~/media/cancer.ca/CW/cancer%20information/cancer%20101/Canadian%20cancer%20statistics/Canadian-Cancer-Statistics-2015-EN.pdf).
12. Centers for Medicare & Medicaid Services, National Coverage Determination (NCD) for Screening for Lung Cancer with Low Dose Computed Tomography (LDCT). (Available from:) https://www.cms.gov/Newsroom/MediaReleaseDatabase/Press-releases/2015-Press-releases-items/2015-02-05.html ([Internet]).
13. Couraud, S., Barlési, F., Lemarié, E., Zalcman, G., Milleron, B., From the NLST randomized trial to the clinic: how should we implement individual lung cancer screening in clinical practice?., 30(1), 2013, 15 (Available from: http://www.ncbi.nlm.nih.gov/pubmed/23318184).
14. Crestanello, J.A., Allen, M.S., Jett, J.R., Cassivi, S.D., Nichols, F.C. 3rd, Swensen, S.J., et al. Thoracic surgical operations in patients enrolled in a computed tomographic screening trial. J. Thorac. Cardiovasc. Surg. 128:2 (2004), 254–259 (Available from: http://www.ncbi.nlm.nih.gov/pubmed/15282462).
15. Croswell, J.M., Baker, S.G., Marcus, P.M., Clapp, J.D., Kramer, B.S., Cumulative incidence of false-positive test results in lung cancer screening: a randomized trial. Erratum in: Ann Intern Med. 2010 Jun 1;152(11):759. Ann. Intern. Med. 152:8 (2010), 505–512 (Available from: http://www.ncbi.nlm.nih.gov/pubmed/20404381).
16. Dales, L.G., Friedman, G.D., Collen, M.F., Evaluating periodic multiphasic health checkups: a controlled trial. J. Chronic Dis. 32:5 (1979), 385–404 (Available from: http://www.ncbi.nlm.nih.gov/pubmed/109452).
17. Deeks JJ, Higgins JP, Altman DG, The Cochrane Statistical Methods Group. Analysing data and undertaking meta-analyses. In: Higgins J. P., Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 510 [updated March 2011]: The Cochrane Collaboration; 2011.
18. DerSimonian, R., Laird, N., Meta-analysis in clinical trials. Control. Clin. Trials 7:3 (1986), 177–188 (Available from: http://www.ncbi.nlm.nih.gov/pubmed/3802833).
19. Detterbeck, F.C., Mazzone, P.J., Naidich, D.P., Bach, P.B., Screening for lung cancer: diagnosis and management of lung cancer: American College of Chest Physicians evidence-based clinical practice guidelines., 143(5_Suppl.), 2013, e78S–e92S (Available from).
20. Diederich, S., Thomas, M., Semik, M., Lenzen, H., Roos, N., Weber, A., et al. Screening for early lung cancer with low-dose spiral computed tomography: results of annual follow-up examinations in asymptomatic smokers. Eur. Radiol. 14:4 (2004), 691–702 (Available from: http://www.ncbi.nlm.nih.gov/pubmed/14727146).
21. Distiller (DistillerSR systematic review software), Ottawa, ON: Evidence Partners. (Available from:) http://systematic-review.net/ ([computer program]).
22. Dominioni, L., Rotolo, N., Mantovani, W., Poli, A., Pisani, S., Conti, V., et al. A population-based cohort study of chest X-ray screening in smokers: lung cancer detection findings and follow-up. BMC Cancer, 12, 2012, 18 (Available from: http://www.ncbi.nlm.nih.gov/pubmed/22251777).
23. Duffy, S.W., Field, J.K., Allgood, P.C., Seigneurin, A., Translation of research results to simple estimates of the likely effect of a lung cancer screening programme in the United Kingdom. Br. J. Cancer 110:7 (2014), 1834–1840 (Available from: http://www.ncbi.nlm.nih.gov/pubmed/24525696).
24. Field, J.K., Chen, Y., Marcus, M.W., McRonald, F.E., Raji, O.Y., Duffy, S.W., The contribution of risk prediction models to early detection of lung cancer. J. Surg. Oncol. 108:5 (2013), 304–311 (Available from: http://www.ncbi.nlm.nih.gov/pubmed/23996507).
25. Field, J.K., Devaraj, A., Baldwin, D.R., Holemans, J., Screaton, N., Ledson, M., et al. UK Lung Cancer Screening trial (UKLS): prevalence data at baseline., 83(29), 2014, S24–S25 (Available from: http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=cctr&AN=CN-01011374).
26. Flehinger, B.J., Kimmel, M., The natural history of lung cancer in a periodically screened population. Biometrics 43:1 (1987), 127–144 (Available from: http://www.ncbi.nlm.nih.gov/pubmed/3567302).
27. Gareen, I.F., Duan, F., Greco, E.M., Snyder, B.S., Boiselle, P.M., Park, E.R., et al. Impact of lung cancer screening results on participant health-related quality of life and state anxiety in the National Lung Screening Trial. Cancer 120:21 (2014), 3401–3409 (Available from: http://www.ncbi.nlm.nih.gov/pubmed/25065710).
28. Gohagan, J., Marcus, P., Fagerstrom, R., Pinsky, P., Kramer, B., Prorok, P., et al. Baseline findings of a randomized feasibility trial of lung cancer screening with spiral CT scan vs chest radiograph: the Lung Screening Study of the National Cancer Institute. Chest 126:1 (2004), 114–121 (Available from: http://www.ncbi.nlm.nih.gov/pubmed/15249451).
29. Goulart, B.H.L., Ramsey, S.D., Moving beyond the National Lung Screening Trial: discussing strategies for implementation of lung cancer screening programs. Oncologist 18:8 (2013), 941–946 (Available from: http://www.ncbi.nlm.nih.gov/pubmed/23873718).
30. GRADE working group, Place published Unknown: The GRADE working group., 2005 (Available from:) http://www.gradeworkinggroup.org/.
31. GRADEpro, Version 3.2 for Windows. (Available from:) http://www.guidelinedevelopment.org/ ([Computer program]).
32. Henschke, C.I., McCauley, D.I., Yankelevitz, D.F., Naidich, D.P., McGuinness, G., Miettinen, O.S., et al. Early lung cancer action project: a summary of the findings on baseline screening. Oncologist 6:2 (2001), 147–152 (Available from: http://theoncologist.alphamedpress.org/content/6/2/147.abstract).
33. Higgins, J.P.T., Altman, D.G., Sterne, J.A.C., The Cochrane Statistical Methods Group, The Cochrane Bias Methods Group. Assessing risk of bias in included studies. Higgins, J.P.T., Green, S., (eds.) Cochrane Handbook for Systematic Reviews of Interventions Version 510 [updated March 2011], 2011, The Cochrane Collaboration.
34. Horeweg, N., van der Aalst, C.M., Thunnissen, E., Nackaerts, K., Weenink, C., Groen, H.J.M., et al. Characteristics of lung cancers detected by computer tomography screening in the randomized NELSON trial. Am. J. Respir. Crit. Care Med. 187:8 (2013), 848–854 (Available from: http://www.ncbi.nlm.nih.gov/pubmed/23348977).
35. Horeweg, N., van der Aalst, C.M., Vliegenthart, R., Zhao, Y.R., Xie, X., Scholten, E.T., et al. Volumetric computed tomography screening for lung cancer: three rounds of the NELSON trial. Eur. Respir. J. 42:6 (2013), 1659–1667 (Available from: http://www.ncbi.nlm.nih.gov/pubmed/23845716).
36. Horeweg, N., Scholten, E.T., de Jong, P.A., van der Aalst, C.M., Weenink, C., Lammers, J.W., et al. Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers. Lancet Oncol. 15:12 (2014), 1342–1350 (Available from: http://www.ncbi.nlm.nih.gov/pubmed/25282284).
37. Humphrey, L., Deffebach, M., Pappas, M., Baumann, C., Artis, K., Priest Mitchell, J., et al. Screening for lung cancer: systematic review to update the U.S. Preventive Services Task Force Recommendation. 2013 (Rockville, MD, 13-05188-EF-1. Available from: http://www.ncbi.nlm.nih.gov/books/NBK154610/).
38. Infante, M., Lutman, F.R., Cavuto, S., Brambilla, G., Chiesa, G., Passera, E., et al. Lung cancer screening with spiral CT: baseline results of the randomized DANTE trial. Lung Cancer 59:3 (2008), 355–363 (Available from: http://www.ncbi.nlm.nih.gov/pubmed/17936405).
39. Infante, M., Cavuto, S., Lutman, F.R., Brambilla, G., Chiesa, G., Ceresoli, G., et al. A randomized study of lung cancer screening with spiral computed tomography: three-year results from the DANTE trial. Am. J. Respir. Crit. Care Med. 180:5 (2009), 445–453 (Available from: http://www.ncbi.nlm.nih.gov/pubmed/19520905).
40. Infante, M., Cavuto, S., Lutman, F.R., Passera, E., Chiarenza, M., Chiesa, G., et al. Long-term follow-up results of the DANTE trial, a randomized study of lung cancer screening with spiral computed tomography. Am. J. Respir. Crit. Care Med. 191:10 (2015), 1166–1175 (Available from: http://www.ncbi.nlm.nih.gov/pubmed/25760561).
41. Jaklitsch, M.T., Jacobson, F.L., Austin, J.H.M., Field, J.K., Jett, J.R., Keshavjee, S., et al. The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups. J. Thorac. Cardiovasc. Surg. 144:1 (2012), 33–38 (Available from: http://www.sciencedirect.com/science/article/pii/S0022522312006009).
42. Jaklitsch, M.T., Jacobson, F.L., Austin, J.H., Field, J.K., Jett, J.R., Keshavjee, S., et al. The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups., 144(1), 2012, 33–38 (Available from).
43. Kubik, A., Haerting, J., Survival and mortality in a randomized study of lung cancer detection. Neoplasma 37:4 (1990), 467–475 (Available from: http://www.ncbi.nlm.nih.gov/pubmed/2234207).
44. Lopes Pegna, A., Picozzi, G., Mascalchi, M., Carozzi, F.M., Carrozzi, L., Comin, C., et al. Design, recruitment and baseline results of the ITALUNG trial for lung cancer screening with low-dose CT. Lung Cancer 64:1 (2009), 34–40 (Available from: http://www.ncbi.nlm.nih.gov/pubmed/18723240).
45. Lopes Pegna, A., Picozzi, G., Falaschi, F., Carrozzi, L., Falchini, M., Carozzi, F.M., et al. Four-year results of low-dose CT screening and nodule management in the ITALUNG trial. J. Thorac. Oncol. 8:7 (2013), 866–875 (Available from: http://www.ncbi.nlm.nih.gov/pubmed/23612465).
46. MacRedmond, R., McVey, G., Lee, M., Costello, R.W., Kenny, D., Foley, C., et al. Screening for lung cancer using low dose CT scanning: results of 2 year follow up. Thorax 61:1 (2006), 54–56 (Available from: http://www.ncbi.nlm.nih.gov/pubmed/16396954).
47. Manser, R., Lethaby, A., Irving, L.B., Stone, C., Byrnes, G., Abramson, M.J., et al. Screening for lung cancer. Cochrane Database Syst. Rev., 6, 2013, CD001991 (Available from: http://www.ncbi.nlm.nih.gov/pubmed/23794187).
48. Marcus, P.M., Bergstralh, E.J., Zweig, M.H., Harris, A., Offord, K.P., Fontana, R.S., Extended lung cancer incidence follow-up in the Mayo Lung Project and overdiagnosis. J. Natl. Cancer Inst. 98:11 (2006), 748–756 (Available from: http://www.ncbi.nlm.nih.gov/pubmed/16757699).
49. Mazzone, P.J., Obuchowski, N., Fu, A.Z., Phillips, M., Meziane, M., Quality of life and healthcare use in a randomized controlled lung cancer screening study. Ann. Am. Thorac. Soc. 10:4 (2013), 324–329 (Available from: http://www.ncbi.nlm.nih.gov/pubmed/23952850).
50. Menezes, R.J., Roberts, H.C., Paul, N.S., McGregor, M., Chung, T.B., Patsios, D., et al. Lung cancer screening using low-dose computed tomography in at-risk individuals: the Toronto experience. Lung Cancer 67:2 (2010), 177–183 (Available from: http://www.ncbi.nlm.nih.gov/pubmed/19427055).
51. Moyer, V.A., U. S. Preventive Services Task Force, Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement. Ann. Intern. Med. 160:5 (2014), 330–338 (Available from: http://www.ncbi.nlm.nih.gov/pubmed/?term=24378917).
52. Lung cancer detection by chest X-rays at 6 monthly intervals. N. S. Med. Bull., 49(1), 1970, 14–15 (Available from: http://www.ncbi.nlm.nih.gov/pubmed/5262952).
53. Nahorecki, A., Chabowski, M., Kuzniar, T., Kedzierski, B., Jazwiec, P., Szuba, A., et al. Low-dose computer tomography as a screening tool for lung cancer in a high risk population. Adv. Exp. Med. Biol. 852 (2015), 31–37 (Available from: http://www.ncbi.nlm.nih.gov/pubmed/25634127).
54. National Comprehensive Cancer Network, NCCN guidelines for patients. 2014 ([Internet], Fort Washington, PA, Available from: http://www.nccn.org/patients/guidelines/lung_screening/index.html).
55. National Lung Screening Trial, NLST medical complications of diagnostic evaluation for lung cancer: data dictionary., 2014 (Available from:) https://biometry.nci.nih.gov/cdas/attach/serve/datasetdocumentation/nlst/comprehensive/medical_complications/medical_complications.dictionary.d041614.pdf.
56. National Lung Screening Trial Research Team, Aberle, D.R., Adams, A.M., Berg, C.D., Black, W.C., Clapp, J.D., et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N. Engl. J. Med. 365:5 (2011), 395–409 (Available from: http://www.ncbi.nlm.nih.gov/pubmed/21714641).).
57. Oken, M.M., Hocking, W.G., Kvale, P.A., Andriole, G.L., Buys, S.S., Church, T.R., et al. Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trial. JAMA 306:17 (2011), 1865–1873 (Available from: http://www.ncbi.nlm.nih.gov/pubmed/22031728).
58. Palda, V.A., Van Spall, H.G.C., Canadian Task Force on Preventive Health Care, Care Canadian Task Force on Preventive Health, Screening for Lung Cancer: Updated recommendations from the Canadian Task Force on Preventive Health Care. Ottawa, ON., 2003 (Available from:) http://canadiantaskforce.ca/perch/resources/update-recommendations.pdf.
59. Pastorino, U., Bellomi, M., Landoni, C., De Fiori, E., Arnaldi, P., Picchio, M., et al. Early lung-cancer detection with spiral CT and positron emission tomography in heavy smokers: 2-year results. Lancet 362:9384 (2003), 593–597 (Available from: http://www.ncbi.nlm.nih.gov/pubmed/12944057).
60. Pastorino, U., Rossi, M., Rosato, V., Marchiano, A., Sverzellati, N., Morosi, C., et al. Annual or biennial CT screening versus observation in heavy smokers: 5-year results of the MILD trial. Eur. J. Cancer Prev. 21:3 (2012), 308–315 (Available from: http://www.ncbi.nlm.nih.gov/pubmed/22465911).
61. Patz, E.F. Jr., Pinsky, P., Gatsonis, C., Sicks, J.D., Kramer, B.S., Tammemagi, M.C., et al. Overdiagnosis in low-dose computed tomography screening for lung cancer. JAMA Intern. Med. 174:2 (2014), 269–274 (Available from: http://www.ncbi.nlm.nih.gov/pubmed/24322569).
62. Peirson, L., Fitzpatrick-Lewis, D., Morrison, K., Warren, R., Usman Ali, M., Raina, P., Treatment of overweight and obesity in children and youth: a systematic review and meta-analysis., 3(1), 2015, E35–E46 (Available from: http://www.cmajopen.ca/content/3/1/E35.abstract).
63. Petersen, R.H., Hansen, H.J., Dirksen, A., Pedersen, J.H., Lung cancer screening and video-assisted thoracic surgery. J. Thorac. Oncol. 7:6 (2012), 1026–1031 (Available from: http://www.ncbi.nlm.nih.gov/pubmed/22588154).
64. Pinsky, P.F., Gierada, D.S., Hocking, W., Patz, E.F. Jr., Kramer, B.S., National Lung Screening Trial findings by age: Medicare-eligible versus under-65 population. Ann. Intern. Med. 161:9 (2014), 627–633 (Available from: http://www.ncbi.nlm.nih.gov/pubmed/25199624).
65. Pinsky, P.F., Gierada, D.S., Black, W., Munden, R., Nath, H., Aberle, D., et al. Performance of Lung-RADS in the National Lung Screening Trial: a retrospective assessment. Ann. Intern. Med. 162:7 (2015), 485–491 (Available from: http://www.ncbi.nlm.nih.gov/pubmed/25664444).
66. Rasmussen, J.F., Siersma, V., Pedersen, J.H., Brodersen, J., Psychosocial consequences in the Danish randomised controlled lung cancer screening trial (DLCST). Lung Cancer 87:1 (2015), 65–72 (Available from: http://www.ncbi.nlm.nih.gov/pubmed/25433982).
67. Review Manager (RevMan), Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration. (Available from:) http://tech.cochrane.org/revman/download ([Computer Program]).
68. Roberts, H., Walker-Dilks, C., Sivjee, K., Ung, Y., Yasufuku, K., Hey, A., et al. Screening high-risk populations for lung cancer. Toronto, ON. Program in Evidence-based Care Evidence-based Series No.: 15–10, 2013 (Available from: http://www.cancercare.on.ca/common/pages/UserFile.aspx?fileId=287879).
69. Roberts, H., Walker-Dilks, C., Sivjee, K., Ung, Y., Yasufuku, K., Hey, A., et al. Screening high-risk populations for lung cancer: guideline recommendations., 8(10), 2013, 1232–1237 (Available from).
70. Rzyman, W., Jelitto-Gorska, M., Dziedzic, R., Biadacz, I., Ksiazek, J., Chwirot, P., et al. Diagnostic work-up and surgery in participants of the Gdansk lung cancer screening programme: the incidence of surgery for non-malignant conditions. Interact. Cardiovasc. Thorac. Surg. 17:6 (2013), 969–973 (Available from: http://www.ncbi.nlm.nih.gov/pubmed/24008181).
71. Rzyman, W., Dziedzic, R., Jelitto-Gorska, M., Biadacz, I., Ksiazek, J., Siebert, J., et al. Results of an “open access” lung cancer screening program with low-dose computed tomography in 8649 healthy volunteers in Gdansk. Pol. Arch. Med. Wewn. 125:4 (2015), 232–239 (Available from: http://www.ncbi.nlm.nih.gov/pubmed/25764248).
72. Saghir, Z., Dirksen, A., Ashraf, H., Bach, K.S., Brodersen, J., Clementsen, P.F., et al. CT screening for lung cancer brings forward early disease. The randomised Danish Lung Cancer Screening Trial: status after five annual screening rounds with low-dose CT. Thorax 67:4 (2012), 296–301 (Available from: http://www.ncbi.nlm.nih.gov/pubmed/22286927).
73. SEER Cancer Statistics Factsheets: Lung and Bronchus Cancer. Bethesda, MD: National Cancer Institute,. (Available from: http://seer.cancer.gov/statfacts/html/lungb.html).
74. Shamseer, L., Moher, D., Clarke, M., Ghersi, D., Liberati, A., Petticrew, M., et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ, 349, 2015, g7647 (Available from: http://www.ncbi.nlm.nih.gov/pubmed/25555855).
75. Shea, B.J., Grimshaw, J.M., Wells, G.A., Boers, M., Andersson, N., Hamel, C., et al. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Med. Res. Methodol. 7:1 (2007), 10–16 (Available from: http://www.ncbi.nlm.nih.gov/pubmed/17302989).
76. Sobue, T., Moriyama, N., Kaneko, M., Kusumoto, M., Kobayashi, T., Tsuchiya, R., et al. Screening for lung cancer with low-dose helical computed tomography: anti-lung cancer association project. J. Clin. Oncol. 20:4 (2002), 911–920 (Available from: http://www.ncbi.nlm.nih.gov/pubmed/11844811).
77. Sone, S., Nakayama, T., Honda, T., Tsushima, K., Li, F., Haniuda, M., et al. Long-term follow-up study of a population-based 1996–1998 mass screening programme for lung cancer using mobile low-dose spiral computed tomography. Lung Cancer 58:3 (2007), 329–341 (Available from: http://www.ncbi.nlm.nih.gov/pubmed/17675180).
78. Stata statistical software [Computer Program]: release 12. Station, TX: StataCorp LP. (Available from: http://www.stata.com/).
79. Swensen, S.J., Jett, J.R., Hartman, T.E., Midthun, D.E., Mandrekar, S.J., Hillman, S.L., et al. CT screening for lung cancer: five-year prospective experience. Radiology 235:1 (2005), 259–265 (Available from: http://www.ncbi.nlm.nih.gov/pubmed/15695622).
80. U. S. Preventive Services Task Force, Lung cancer screening: recommendation statement. Ann. Intern. Med. 140:9 (2004), 738–739 (Available from: http://www.ncbi.nlm.nih.gov/pubmed/?term=15126258).
81. U.S. Preventive Services Task Force, Screening for lung cancer: draft recommendation statement. AHRQ Publication No. 13–05196-EF-3, 2013 (Available from: http://www.uspreventiveservicestaskforce.org/3rduspstf/lungcancer/lungcanrs.htm).
82. van den Bergh, K.A., Essink-Bot, M.L., Borsboom, G.J., Th Scholten, E., Prokop, M., de Koning, H.J., et al. Short-term health-related quality of life consequences in a lung cancer CT screening trial (NELSON). Br. J. Cancer 102:1 (2010), 27–34 (Available from: http://www.ncbi.nlm.nih.gov/pubmed/19935789).
83. van Iersel, C.A., de Koning, H.J., Draisma, G., Mali, W.P.T.M., Scholten, E.T., Nackaerts, K., et al. Risk-based selection from the general population in a screening trial: selection criteria, recruitment and power for the Dutch–Belgian randomised lung cancer multi-slice CT screening trial (NELSON). Int. J. Cancer 120:4 (2007), 868–874, 10.1002/ijc.22134 (Available from:).
84. Veronesi, G., Bellomi, M., Mulshine, J.L., Pelosi, G., Scanagatta, P., Paganelli, G., et al. Lung cancer screening with low-dose computed tomography: a non-invasive diagnostic protocol for baseline lung nodules. Lung Cancer 61:3 (2008), 340–349 (Available from: http://www.ncbi.nlm.nih.gov/pubmed/18308420).
85. Veronesi, G., Maisonneuve, P., Bellomi, M., Rampinelli, C., Durli, I., Bertolotti, R., et al. Estimating overdiagnosis in low-dose computed tomography screening for lung cancer: a cohort study. Ann. Intern. Med. 157:11 (2012), 776–784 (Available from: http://www.ncbi.nlm.nih.gov/pubmed/23208167).
86. Wallis, S., Binomial confidence intervals and contingency tests: mathematical fundamentals and the evaluation of alternative methods. JQL 20:3 (2013), 178–208 (Available from: http://corplingstats.wordpress.com/2012/03/31/binomial-distributions/).
87. Wender, R., Fontham, E.T.H., Barrera, E. Jr., Colditz, G.A., Church, T.R., Ettinger, D.S., et al. American Cancer Society lung cancer screening guidelines. CA Cancer J. Clin. 63:2 (2013), 107–117 (Available from: http://www.ncbi.nlm.nih.gov/pubmed/?term=23315954).
88. Wender, R., Fontham, E.T., Barrera, E., Colditz, G.A., Church, T.R., Ettinger, D.S., et al. American Cancer Society lung cancer screening guidelines., 63(2), 2013, 106–117 (Available from).
89. Wilde, J., A 10 year follow-up of semi-annual screening for early detection of lung cancer in the Erfurt County, GDR. Eur. Respir. J. 2:7 (1989), 656–662 (Available from: http://www.ncbi.nlm.nih.gov/pubmed/2776873).
90. Wilson, D.O., Weissfeld, J.L., Fuhrman, C.R., Fisher, S.N., Balogh, P., Landreneau, R.J., et al. The Pittsburgh Lung Screening Study (PLuSS): outcomes within 3 years of a first computed tomography scan. Am. J. Respir. Crit. Care Med. 178:9 (2008), 956–961 (Available from: http://www.ncbi.nlm.nih.gov/pubmed/18635890).